Queen Elizabeth II Health Sciences Center
Halifax, Nova Scotia B3K6A3
3 studies enrolling now · 28 studies all time
What they study most
Alpha1-Antitrypsin Deficiency, Angiotensin Converting Enzyme Inhibitor Induced Angioedema, Atherosclerosis, Brain Edema, Brain Tumor, Cardiovascular Diseases, Cerebrovascular Accident, Cholangiocarcinoma, Chronic Lymphocytic Leukemia, Coronary Disease, Cystic Fibrosis, Cytomegalovirus (CMV)
Studies at this site
- Selinexor and Backbone Treatments of Multiple Myeloma Patients — Recruiting now
- Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS) — Recruiting now
- The Dragon PLC Trial (DRAGON-PLC) — Recruiting now
- Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
- Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction — Completed
- Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
- A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants — Completed
- Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed
- Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema — Completed
- Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia — Completed
- A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed
- Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
- A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma — Stopped early
- Augment® Bone Graft (Formerly GEM OS™1 Bone Graft) Compared to Autologous Bone Graft in Foot and Ankle Fusions — Completed
- Simvastatin Therapy for Moderate and Severe COPD — Stopped early
- Expanded Access Program for Maraviroc At Multiple Centers — Completed
- Niacin Plus Statin to Prevent Vascular Events — Stopped early
- Fluid Lavage of Open Wounds — Completed
- An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer — Completed
- XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors — Completed
- Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure — Completed
- An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies — Completed
- Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis — Paused
- Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients — Stopped early
- A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis — Completed
- Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
- A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed